Find Academic Supervisors

• Neurology
• Neurodegenerative Diseases
• Inflammatory Diseases
• +5 more

Professor Gabriele DeLuca is a leading academic at the University of Oxford , serving as Professor of Clinical Neurology and Experimental Neuropathology, Honorary Consultant Neurologist, and Director of Clinical Neurosciences Undergraduate Education. He co-leads the Oxford-Quinnipiac-Trinity Health Of New England Partnership to advance neuro-rehabilitation research and education. Academic Roles: Director of Clinical Neurosciences Undergraduate Education, Co-Director of Oxford-Quinnipiac Partnership Research Focus: Neuropathology of multiple sclerosis, traumatic brain injury, dementia, and vascular diseases His research integrates clinical neurology and rehabilitation, aiming to translate post-mortem tissue analysis into therapeutic targets for living patients. Current projects explore neuroinflammation, amyloid pathology, and neurovascular hypotheses in neurodegenerative conditions. Recent scientific recognition includes the Vice Chancellor's Award (2025) and multiple Teaching Excellence Awards (2022-2025). He holds fellowships from the Royal College of Pathologists (FRCPath) and American Academy of Neurology (FAAN), alongside the Cavanagh Prize in Neuropathology (2017). Key Funding: Rosetrees Trust (2025-2028), UK MS Society (2023-2026), Department of Defense (2021-2025) Leadership: Inaugural chair of Leadership University (AAN), co-leader of UK MS Leadership Academy

Geoffrey PittView profile

Professor

• Neuroscience
• Cardiology
• Molecular Biology
• +7 more

Geoffrey Pitt serves as Professor of Neuroscience at the Brain and Mind Research Institute and Ida and Theo Rossi Distinguished Professor of Medicine in the Department of Medicine at Weill Cornell Medical College. His dual appointments reflect his interdisciplinary research bridging neuroscience, cardiology, and molecular biology. Dr. Pitt completed his education with a B.A. from Yale University (1984), Sc.M. from The Johns Hopkins University (1987), and M.D., Ph.D. from The Johns Hopkins University School of Medicine (1993). His research focuses on ion channel regulation, particularly calcium and sodium channels, with emphasis on FGF13 protein's role in cardiac and neuronal function. His work spans cardiac electrophysiology, Timothy syndrome (CACNA1C-related disorders), arrhythmia mechanisms, and metabolic disorders linked to ion channel dysfunction. Recent publications reveal his exploration of epigenetic regulation in cardiac development and the intersection of metabolic health with channel function. Dr. Pitt leads multiple significant research initiatives including the Mechanistic re-evaluation of fibroblast growth factor homologous factors in the heart (NHLBI, 2025-2029) and Phosphorylation-dependent regulation of calcium channels by macromolecular complexes (NICHD, 2023-2027). He also serves as Principal Investigator for the Multidisciplinary Research Training in Cardiovascular Disease program (NHLBI, 2022-2027). As an active member of the scientific community, Dr. Pitt serves on the Advisory/Scientific Board for Tevard Biosciences and maintains interests with the Cardiovascular Research Foundation and the Journal of the American College of Cardiology Basic to Translational Science.

Manuel Luís CapelasView profile

Associate Professor

• Palliative Care
• End-of-Life Care
• Symptomatic Treatment
• +5 more

Manuel Luís Capelas serves as an Associate Professor at the Faculty of Health Sciences and Nursing of the Universidade Católica Portuguesa (UCP), following the transformation of the Institute of Health Sciences in September 2023. He is also a Researcher at the Center for Interdisciplinary Research in Health (CIIS) at UCP and maintains an active research profile with 327 research outputs and an h-index of 11. His professional affiliations include membership on the Scientific Council of the Bioethics Institute of UCP (2020-2021) and leadership roles in palliative care organizations. His educational background includes a Bachelor's degree in Nursing from the Franciscan Missionary School of Nursing of Mary (1989), a Master's in Palliative Care from the Faculty of Medicine of the University of Lisbon (2006), and a PhD in Health Sciences-Palliative Care from the Institute of Health Sciences of UCP (2013). Dr. Capelas specializes in palliative care research with particular expertise in end-of-life care, symptomatic treatment, and quality of life assessment. His work spans multiple contexts including prison healthcare settings, oncology, and nursing education. He has made significant contributions to understanding palliative care delivery systems and ethical considerations in healthcare. His recent scholarly output demonstrates continued productivity with multiple publications in 2025 focusing on palliative care applications in diverse clinical settings including oncology, prison healthcare, and lung cancer management. These works reflect his interdisciplinary approach connecting medical, ethical, and practical aspects of care delivery. International Ageing Award 2018 Sócio Honorário da Associação Portuguesa de Cuidados Paliativos (2019) Dr. Capelas actively supervises research and has participated in numerous projects including NursesMH#Survey2023, MIMi (Imminent Death in Internal Medicine), and ICTOLL_CARE. His grant portfolio demonstrates strong institutional support for his research on palliative care, mental health of nurses, and innovative care delivery models. As Director of the Portuguese Observatory of Palliative Care at UCP, he oversees significant initiatives in this field. As Director of the Portuguese Observatory of Palliative Care and former President of the LInQUE Health Ethics Committee (2021-2023), Dr. Capelas leads important institutional efforts in palliative care research and ethics. His involvement with the European Association for Palliative Care Task Forces demonstrates his international standing in the field, particularly regarding palliative care in prisons and nursing education.

Sean MillardView profile

Associate Professor

• Neurosciences
• Molecular Biology
• Drosophila Genetics
• +4 more

Associate Professor Sean Millard is affiliated with the University of Queensland as an Affiliate Associate Professor at the Queensland Brain Institute and the Centre for Motor Neuron Disease Research , both under the Faculty of Health, Medicine and Behavioural Sciences . He is also an Associate Professor at the School of Biomedical Sciences . His academic journey began with a BA in Biology from Columbia University , followed by a PhD in Molecular Biology from Weill Cornell Graduate School of Medical Sciences . Postdoctoral work in Larry Zipursky's lab at UCLA established his focus on Drosophila genetics and Dscam-family proteins . Research interests center on molecular mechanisms for brain wiring specificity , exploring how Dscam2 performs neuron-specific functions despite broad expression. His work addresses synaptic dysfunction in neurological diseases , using Drosophila melanogaster as a model organism. Additional projects investigate mitophagy regulation via SCFFBXL4-PPTC7 and the role of WDR62 in glial growth and microcephaly. Recent publications highlight his contributions to mitophagy receptors , neurotransmission , and venom composition evolution . He actively supervises PhD and Master’s students in projects related to neurodevelopmental mechanisms , synaptic disease models , and cell signaling .

• Exercise Physiology
• Nutritional Interventions
• Muscle Health
• +7 more

Professor Theocharis Ispoglou is a leading academic at Leeds Beckett University's Carnegie School of Sport , specializing in Exercise and Nutritional Sciences . With over two decades of experience, his research bridges laboratory findings with practical applications for muscle health, ageing, and metabolic conditions. Professor at Leeds Beckett University Director of Centre for Active Lifestyles and Healthy Ageing (ACTLIFE) Researcher at Centre for Human Performance Research Focus: Combats sarcopenia through nutritional interventions (e.g., protein/EAA supplementation) and exercise regimes. His work informs clinical practices for the NHS, drives public health initiatives, and collaborates with industry for commercializing nutritional products. Scientific Contributions: 15 recent articles highlight his expertise in muscle physiology, cancer cachexia, cardiac rehabilitation, and digital health tools. Key sub-fields include metabolic health, endocrine responses to exercise, and cross-sectional studies in NHANES datasets. Teaching & Mentorship: Delivers modules in Physiology and Biochemistry for Performance and Major Independent Study , shaping future health professionals.

• Oncology
• Cancer Rehabilitation
• Exercise Oncology
• +3 more

Morten Quist serves as an Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with a specialized focus in Clinical Oncology. His clinical affiliation appears to be with the Copenhagen University Hospital (Region Hovedstaden), as indicated by his email domain (regionh.dk). Dr. Quist's research interests center on oncology rehabilitation, particularly examining the intersection of exercise science and cancer care. His work focuses on lung cancer rehabilitation, exercise interventions for patients with advanced disease, and management of complications such as sarcopenia and bone metastases. He has developed expertise in understanding barriers to rehabilitation participation and creating supportive care interventions for vulnerable populations including older adults with cancer. Analysis of his recent publications reveals a strong focus on clinical applications of exercise oncology, with particular attention to quality of life outcomes, patient participation barriers, and evidence-based exercise recommendations for specific cancer populations. His work often takes the form of systematic reviews, meta-analyses, and clinical guidelines that bridge research and practice. His collaborative research network spans multiple institutions and countries, as evidenced by the international authorship on many of his publications. He frequently collaborates with researchers in exercise physiology, medical oncology, geriatrics, and supportive cancer care. Dr. Quist contributes significantly to the development of clinical guidelines in cancer rehabilitation, particularly evidenced by his work on exercise recommendations for patients with bone metastases. His research demonstrates a commitment to translating evidence into practical clinical applications that improve patient outcomes across the cancer continuum.

• Metabolomics
• Metabolic Disorders
• Obesity Research
• +5 more

Thomas Moritz is a Professor at the University of Copenhagen, Faculty of Health and Medical Sciences, Department of Biomedical Sciences, where he leads the Moritz Group focused on metabolic research. His work bridges basic science with clinical applications in metabolic disorders. His research interests span metabolomics, lipidomics, skeletal muscle metabolism, adipocyte biology, and circadian regulation of metabolism. Dr. Moritz employs multi-omics approaches to investigate metabolic pathways in obesity, inflammatory bowel disease, and inherited metabolic disorders. His work often focuses on how cellular metabolism responds to environmental factors like exercise timing and nutritional interventions. Dr. Moritz's recent publications demonstrate significant contributions to understanding metabolic regulation across multiple physiological systems. His work shows particular strength in integrating metabolomics with other 'omics' technologies to reveal novel insights into metabolic diseases. His research has been widely disseminated, with 233 research outputs including 229 journal articles, 2 conference abstracts, 1 comment/debate, and 1 review. Metabolomics and diagnostic algorithms for metabolic disorders Adipocyte biology and obesity-related inflammation Skeletal muscle metabolism and exercise physiology Circadian regulation of metabolic processes Lipidomics in inflammatory diseases His research has garnered significant attention across academic and social media platforms, with mentions across X (Twitter), Bluesky, Mendeley, news outlets, and scientific blogs, indicating substantial impact in the metabolic research community.

• Cancer Biology
• Metabolism
• Palliative Care
• +3 more

Jonas Sørensen serves as a Guest Researcher at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, focusing on molecular metabolism in cancer and ageing contexts. His research integrates cancer biology, metabolic dysregulation, and clinical palliative care, with specific emphasis on insulin resistance mechanisms in oncology and cachexia management strategies. This interdisciplinary work bridges laboratory-based cancer metabolism studies with translational clinical applications for ageing cancer patients. His 2023 publications demonstrate methodological diversity—combining systematic reviews with clinical guideline development—while maintaining thematic consistency in cancer metabolism complications. Both articles address critical gaps in oncology care, with the insulin resistance study providing epidemiological insights and the cachexia paper offering practical clinical tools. He operates within the 'Molecular Metabolism in Cancer and Ageing' research group at the University of Copenhagen, contributing to the institution's biomedical oncology portfolio through active international collaborations evident in co-author networks.

Jonas Thue TreebakView profile

Associate Professor

• Metabolic Research
• Diabetes Research
• Obesity Pathogenesis
• +6 more

Jonas Thue Treebak is an Associate Professor at the Faculty of Health and Medical Sciences, University of Copenhagen, where he leads the Treebak Group focused on metabolic research. His work investigates the signaling pathways controlling cellular and whole body glucose and lipid homeostasis using cell-based and animal models. Dr. Treebak's primary research interests include: Metabolic regulation of glucose and lipid homeostasis Insulin signaling pathways and adiposity regulation Type 2 diabetes and obesity pathogenesis Transgenic animal models for metabolic research Circadian regulation of metabolism $$\text{NAD}^+$$ metabolism and its role in cellular function His recent research has explored the intersection of exercise timing, circadian biology, and metabolic health, with significant contributions to understanding how time-of-day affects metabolic responses to physical activity and nutrition. His work has been featured in high-impact journals including Nature Aging, PNAS, and Cell Reports Medicine. Dr. Treebak has published extensively with 148 research outputs including 121 journal articles, 7 reviews, and other scholarly contributions. His research has garnered significant attention, being picked up by numerous news outlets, blogged about, and referenced across social media platforms including X (formerly Twitter), Bluesky, and Facebook.

Ozlem DoganView profile

Associate Professor

• Medical Microbiology
• Medical Mycology
• Host-Pathogen Interaction
• +3 more

Ozlem Dogan is an Associate Professor in the Department of Medical Microbiology at Koç University School of Medicine. Her research focuses on fundamental aspects of medical microbiology and mycology, particularly host-pathogen interactions and antimicrobial resistance mechanisms. She holds a specialization degree from Hacettepe University and completed her Bachelor's at Capital University. Her work spans molecular diagnostics, clinical microbiology, and infectious disease epidemiology. Key research areas: Medical Microbiology, Medical Mycology, Host-Pathogen Interaction Current affiliation: Koç University School of Medicine Email: ozldogan@ku.edu.tr

James TidballView profile

Professor

• Muscular Dystrophy
• Skeletal Muscle Biology
• Immunology
• +4 more

James Tidball is a Professor at the David Geffen School of Medicine , University of California, Los Angeles , affiliated with the Department of Integrative Biology & Physiology and Department of Pathology and Laboratory Medicine . His research focuses on the interplay between the immune system and skeletal muscle in diseases like muscular dystrophy and age-related sarcopenia. Key Research Areas : Muscular dystrophy pathophysiology Immunomodulation of muscle regeneration Nitric oxide signaling in muscle repair Aging-induced muscle wasting His publications highlight groundbreaking work on Klotho gene therapy , macrophage polarization , and NF-κB signaling in muscle diseases. Recent studies examine immune cell-targeted interventions and aging-related epigenetic changes in myogenesis. Technical Approaches : Transgenic mouse models Phenotypic analysis of immune/muscle interactions Pharmaceutical intervention testing

Inger Olaug OttestadView profile

Senior Lecturer

• Cancer
• Malnutrition
• Cachexia
• +3 more

Inger Olaug Ottestad serves as a Senior Lecturer in the Section for Clinical Nutrition at the University of Oslo's Faculty of Medicine. Her academic work centers on the critical intersection of nutrition and clinical care, with particular focus on cancer-related malnutrition and cachexia. She maintains an active research profile with numerous recent publications in high-impact journals. Dr. Ottestad's research interests span cancer nutrition, malnutrition and cachexia, diet and cancer relationships, clinical nutrition practice, and interprofessional collaborative learning. Her work demonstrates a consistent focus on improving nutritional care for vulnerable patient populations, particularly those with cancer or elderly individuals experiencing malnutrition and frailty. She has contributed significantly to systematic reviews examining endpoints in cancer cachexia clinical trials, highlighting her leadership in establishing standardized assessment methods in this specialized field. Her recent publications reveal a clear research trajectory focused on nutritional assessment in clinical settings, particularly regarding cancer cachexia, malnutrition diagnosis barriers, and nutritional interventions for specific populations including the elderly and postpartum women with obesity. Her work frequently appears in journals such as Journal of Cachexia, Sarcopenia and Muscle, Clinical Nutrition Open Science, and Geroscience, indicating her strong standing in both oncology nutrition and geriatric nutrition research communities. As an educator, Dr. Ottestad is responsible for a 4-week hospital internship and serves as course responsible for ERN4030: Advanced Clinical Nutrition 1. She also lectures on multiple courses including Introduction to Clinical Nutrition, Physiology and Medical Biochemistry, Preventive Nutrition, and Master's level clinical nutrition courses. She is actively involved in the SamPraks working group, which develops interprofessional collaborative learning across multiple healthcare disciplines including nutrition, pharmacy, medicine, dentistry, psychology, nursing, and theology. Dr. Ottestad maintains active research collaborations with Oslo University Hospital, Norwegian School of Sports Sciences, NTNU, University of Tromsø, and University of Bergen, demonstrating her integration within Norway's broader healthcare research ecosystem. Her work on the QuaNuT study examining nutritional care for malnourished patients across multiple university hospitals highlights her commitment to improving clinical practice through evidence-based research.

• Endocrinology
• Metabolism
• Reproductive Medicine
• +3 more

Anne Jørgensen is a Research Fellow at the Department of Biomedical Sciences, University of Copenhagen, specializing in Endocrinology and Metabolism. Her work bridges molecular biology and clinical applications across reproductive medicine and cancer biology. Research Interests : Endocrinology, metabolism, and molecular mechanisms in reproductive health and cancer models. Contact : Blegdamsvej 3, 2200 København N., anne.joergensen@sund.ku.dk Research Trends : Her recent publications focus on pancreatic islet function, vitamin D's role in fertility, temperature effects on cancer progression, and hormonal impacts on male reproductive and metabolic health.

Joan M EckersonView profile

Professor

• Exercise Nutrition
• Dietary Supplements
• Exercise Performance
• +5 more

Dr. Joan M Eckerson is a Professor in the Department of Exercise Science and Pre-Health Professions within Creighton University's College of Arts and Sciences. Her research program centers on the intersection of nutrition, exercise physiology, and human performance, with particular expertise in dietary supplements like creatine. She investigates their effects on athletic performance, body composition, immune function, and therapeutic applications in clinical populations. Her research interests span: Exercise Nutrition : Efficacy of ergogenic aids (creatine, pre-workout supplements) on athletic outcomes Clinical Applications : Mitigating chemotherapy-induced muscle wasting and cardiotoxicity using creatine/creatinine Physiological Assessment : Developing and validating performance tests (e.g., 3-min rowing test for VO2max estimation) Dietary Interventions : Impact of meal composition on satiety, nutrient intake, and metabolic health Gender-Specific Physiology : Nutritional needs and supplement responses in female athletes across the lifespan. Analysis of her recent publications reveals strong trends in exercise oncology and the immunomodulatory effects of creatine . Her work demonstrates increasing focus on clinical applications beyond athletic performance, particularly using creatine/creatinine to counteract doxorubicin toxicity in skeletal and cardiac muscle. Methodologically, she employs diverse techniques from cellular models (myoblasts) to athlete testing and dietary intervention studies. Dr. Eckerson maintains an active role in scientific dissemination, regularly presenting findings at major conferences including the American College of Sports Medicine (ACSM) and the National Strength and Conditioning Association (NSCA). She also engages in public science communication through radio appearances discussing dietary supplements.

Jalees RehmanView profile

Professor

• Cardiology
• Inflammation
• Lung Infection
• +5 more

Dr. Jalees Rehman serves as Professor of Medicine and Pharmacology and Head of the Department of Biochemistry and Molecular Genetics at the University of Illinois Chicago College of Medicine. His leadership spans institutional administration and cutting-edge biomedical research focused on vascular injury mechanisms. His research expertise encompasses: Organ-specific blood vessel vulnerability (particularly lung vasculature in severe infections) Modulation of inflammatory responses to prevent tissue damage Stem cell-mediated tissue regeneration pathways Machine learning applications for gene regulation analysis in injury/repair processes Recent research trends demonstrate strong integration of computational approaches with vascular biology, particularly in understanding: COVID-19-related vascular complications Post-viral neurological disorders Cancer-associated vascular dysfunction No scientific awards are documented in available sources. His laboratory actively trains graduate students through the Graduate Education in Biomedical Sciences (GEMS) program, particularly within the Cell Biology and Regenerative Medicine concentration. Research is supported by NIH funding within the top-ranked Pharmacology and Regenerative Medicine department. Dr. Rehman's laboratory focuses on vascular injury mechanisms in bacterial/viral infections, utilizing both experimental models and computational tools to identify therapeutic targets for tissue protection and regeneration.